Chemotherapy-induced ovarian failure in young women with early breast cancer: prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials
Background - Young women receiving chemotherapy for early breast cancer (EBC) have a high probability for ovarian failure, defined by chemotherapy-induced amenorrhea (CIA) as a surrogate. CIA is insufficiently reliable and reproducible. We analysed chemotherapy-induced ovarian failure (CIOF) by asse...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
8 June 2021
|
| In: |
European journal of cancer
Year: 2021, Jahrgang: 152, Pages: 193-203 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2021.04.038 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2021.04.038 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804921002902 
|
| Verfasserangaben: | Jenny Furlanetto, Frederik Marmé, Sabine Seiler, Christian Thode, Michael Untch, Sabine Schmatloch, Andreas Schneeweiss, Martina Bassy, Peter A. Fasching, Dominika Strik, Elmar Stickeler, Christian Schem, Thomas Karn, Eva-Maria Grischke, Carsten Denkert, Marion van Mackelenbergh, Volkmar Müller, Valentina Nekljudova, Sibylle Loibl |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1773836692 | ||
| 003 | DE-627 | ||
| 005 | 20240414193455.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211014s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2021.04.038 |2 doi | |
| 035 | |a (DE-627)1773836692 | ||
| 035 | |a (DE-599)KXP1773836692 | ||
| 035 | |a (OCoLC)1341421959 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Furlanetto, Jenny |e VerfasserIn |0 (DE-588)1141798654 |0 (DE-627)1000750841 |0 (DE-576)494512636 |4 aut | |
| 245 | 1 | 0 | |a Chemotherapy-induced ovarian failure in young women with early breast cancer |b prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials |c Jenny Furlanetto, Frederik Marmé, Sabine Seiler, Christian Thode, Michael Untch, Sabine Schmatloch, Andreas Schneeweiss, Martina Bassy, Peter A. Fasching, Dominika Strik, Elmar Stickeler, Christian Schem, Thomas Karn, Eva-Maria Grischke, Carsten Denkert, Marion van Mackelenbergh, Volkmar Müller, Valentina Nekljudova, Sibylle Loibl |
| 264 | 1 | |c 8 June 2021 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.10.2021 | ||
| 520 | |a Background - Young women receiving chemotherapy for early breast cancer (EBC) have a high probability for ovarian failure, defined by chemotherapy-induced amenorrhea (CIA) as a surrogate. CIA is insufficiently reliable and reproducible. We analysed chemotherapy-induced ovarian failure (CIOF) by assessing hormone parameters, CIA, and antral follicle count (AFC). - Methods - Blood samples of women aged ≤45 years treated with anthracycline/taxane-based chemotherapy for EBC from four neoadjuvant/adjuvant trials were collected at baseline, at the end of treatment (EOT), and at 6, 12, 18, and 24 months after EOT. Centrally assessed oestradiol (cutoff <52.2 ng/L) and follicle-stimulating hormone (cutoff >12.4IU/L) were used to define CIOF for patients with baseline premenopausal hormone levels, anti-Müllerian hormone (AMH), and AFC to assess ovarian reserve. Further analyses included CIA, regain of premenopausal hormone levels, and disease-free survival (DFS) also in subgroups. - Results - Six hundred ninety-six patients aged ≤45 years had premenopausal hormone levels at baseline. Overall, 85.1% (592/696) experienced CIOF at EOT, and 147 of 592 had further hormone measurements after EOT. Of those, 32.7% (48/147) regained premenopausal hormone levels after 6 months, 57.9% (66/114) regained premenopausal hormone levels after 12 months, 83.0% (73/88) regained premenopausal hormone levels after 18 months, and 89.2% (74/83) regained premenopausal hormone levels after 24 months. After 24 months, 72.4% (21/29) of patients without CIOF and 100% (14/14) with CIOF had low AMH levels. Four-year DFS without CIOF versus CIOF was 65.9% versus 84.6% (hazard ratio [HR] = 2.09, 95% confidence interval [CI]: 1.37-3.19; P < 0.001); in hormone receptor positive 61.8% versus 87.5% (HR = 2.69, 95% CI: 1.57-4.60; P < 0.001); in <30 years 68.3% versus 92.6% (HR = 4.87, 95% CI: 1.05-22.63; P = 0.026). - Conclusion - Most premenopausal women experienced CIOF after chemotherapy for EBC. After 2 years, nearly all regain premenopausal hormone levels. CIOF was associated with better DFS, especially in patients with hormone receptor-positive EBC or aged <30 years. | ||
| 650 | 4 | |a Chemotherapy-induced amenorrhea | |
| 650 | 4 | |a Chemotherapy-induced ovarian failure | |
| 650 | 4 | |a Early breast cancer | |
| 650 | 4 | |a Ovarian reserve | |
| 650 | 4 | |a Young women | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |e VerfasserIn |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 aut | |
| 700 | 1 | |a Seiler, Sabine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thode, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Untch, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmatloch, Sabine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Bassy, Martina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fasching, Peter A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Strik, Dominika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stickeler, Elmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schem, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Karn, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grischke, Eva-Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Denkert, Carsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a van Mackelenbergh, Marion |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller, Volkmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nekljudova, Valentina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loibl, Sibylle |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 152(2021) vom: Juli, Seite 193-203 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Chemotherapy-induced ovarian failure in young women with early breast cancer prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials |
| 773 | 1 | 8 | |g volume:152 |g year:2021 |g month:07 |g pages:193-203 |g extent:11 |a Chemotherapy-induced ovarian failure in young women with early breast cancer prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2021.04.038 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0959804921002902 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211014 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |d 50000 |e 910000PS109972554 |e 910400PS109972554 |e 50000PS109972554 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 7 | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 50000 |d 60000 |d 61300 |e 50000PM132561972 |e 60000PM132561972 |e 61300PM132561972 |k 0/50000/ |k 0/60000/ |k 1/60000/61300/ |p 2 | ||
| 999 | |a KXP-PPN1773836692 |e 398962945X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Furlanetto, Jenny","family":"Furlanetto","given":"Jenny","role":"aut"},{"role":"aut","given":"Frederik","family":"Marmé","display":"Marmé, Frederik"},{"display":"Seiler, Sabine","family":"Seiler","given":"Sabine","role":"aut"},{"family":"Thode","display":"Thode, Christian","given":"Christian","role":"aut"},{"family":"Untch","display":"Untch, Michael","given":"Michael","role":"aut"},{"role":"aut","given":"Sabine","display":"Schmatloch, Sabine","family":"Schmatloch"},{"role":"aut","given":"Andreas","family":"Schneeweiss","display":"Schneeweiss, Andreas"},{"family":"Bassy","display":"Bassy, Martina","given":"Martina","role":"aut"},{"display":"Fasching, Peter A.","family":"Fasching","given":"Peter A.","role":"aut"},{"display":"Strik, Dominika","family":"Strik","given":"Dominika","role":"aut"},{"role":"aut","given":"Elmar","family":"Stickeler","display":"Stickeler, Elmar"},{"family":"Schem","display":"Schem, Christian","given":"Christian","role":"aut"},{"display":"Karn, Thomas","family":"Karn","role":"aut","given":"Thomas"},{"role":"aut","given":"Eva-Maria","display":"Grischke, Eva-Maria","family":"Grischke"},{"family":"Denkert","display":"Denkert, Carsten","given":"Carsten","role":"aut"},{"display":"van Mackelenbergh, Marion","family":"van Mackelenbergh","given":"Marion","role":"aut"},{"display":"Müller, Volkmar","family":"Müller","role":"aut","given":"Volkmar"},{"display":"Nekljudova, Valentina","family":"Nekljudova","given":"Valentina","role":"aut"},{"given":"Sibylle","role":"aut","family":"Loibl","display":"Loibl, Sibylle"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Chemotherapy-induced ovarian failure in young women with early breast cancer","title_sort":"Chemotherapy-induced ovarian failure in young women with early breast cancer","subtitle":"prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials"}],"note":["Gesehen am 14.10.2021"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"8 June 2021"}],"id":{"doi":["10.1016/j.ejca.2021.04.038"],"eki":["1773836692"]},"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Jenny Furlanetto, Frederik Marmé, Sabine Seiler, Christian Thode, Michael Untch, Sabine Schmatloch, Andreas Schneeweiss, Martina Bassy, Peter A. Fasching, Dominika Strik, Elmar Stickeler, Christian Schem, Thomas Karn, Eva-Maria Grischke, Carsten Denkert, Marion van Mackelenbergh, Volkmar Müller, Valentina Nekljudova, Sibylle Loibl"]},"relHost":[{"corporate":[{"role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"role":"isb","display":"European Association for Cancer Research"},{"display":"European School of Oncology","role":"isb"}],"language":["eng"],"titleAlt":[{"title":"EJC online"}],"part":{"pages":"193-203","year":"2021","extent":"11","text":"152(2021) vom: Juli, Seite 193-203","volume":"152"},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1992-","publisher":"Elsevier ; Pergamon Press","dateIssuedKey":"1992"}],"pubHistory":["28.1992 -"],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"disp":"Chemotherapy-induced ovarian failure in young women with early breast cancer prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trialsEuropean journal of cancer","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"266883400","id":{"zdb":["1468190-0"],"issn":["1879-0852"],"eki":["266883400"]}}],"recId":"1773836692"} | ||
| SRT | |a FURLANETTOCHEMOTHERA8202 | ||